We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$97.8M
2
AAPL icon
Apple
AAPL
+$7.77M
3
COST icon
Costco
COST
+$6.63M
4
FRO icon
Frontline
FRO
+$5.7M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$5.47M

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GALT icon
1551
Galectin Therapeutics
GALT
$348M
$28K ﹤0.01%
+21,534
New +$51.6K
ZURA icon
1552
Zura Bio
ZURA
$566M
$26K ﹤0.01%
+10,552
New +$37.6K
KLTR icon
1553
Kaltura
KLTR
$267M
$22K ﹤0.01%
+10,003
New +$18.3K
OPI
1554
DELISTED
Office Properties Income Trust
OPI
$20K ﹤0.01%
20,230
-302,499
-94% -$467K
CVM icon
1555
CEL-SCI Corp
CVM
$30.1M
$18K ﹤0.01%
+1,525
New +$35.2K
ACET icon
1556
Adicet Bio
ACET
$74.7M
$16K ﹤0.01%
1,048
-1,403
-57% -$26.5K
CBAT icon
1557
CBAK Energy Technology Ltd
CBAT
$57.8M
$15K ﹤0.01%
+16,395
New +$16.4K
CMBM
1558
DELISTED
Cambium Networks
CMBM
$7K ﹤0.01%
10,749
-194,620
-95% -$229K
AAP icon
1559
Advance Auto Parts
AAP
$3.49B
– –
-6,531
Closed -$255K
AAT
1560
American Assets Trust
AAT
$1.4B
– –
-18,153
Closed -$485K
AB icon
1561
AllianceBernstein
AB
$3.47B
– –
-22,537
Closed -$786K
ACRS icon
1562
Aclaris Therapeutics
ACRS
$869M
– –
-255,032
Closed -$293K
ADAP
1563
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-99,662
Closed -$95K
ADMA icon
1564
ADMA Biologics
ADMA
$2.22B
– –
-35,313
Closed -$706K
ADPT icon
1565
Adaptive Biotechnologies
ADPT
$3.97B
– –
-48,165
Closed -$247K
ADSK icon
1566
Autodesk
ADSK
$52.6B
– –
-3,034
Closed -$836K
AEHR icon
1567
Aehr Test Systems
AEHR
$3.36B
– –
-137,861
Closed -$1.77M
AFG icon
1568
American Financial Group
AFG
$12.1B
– –
-4,305
Closed -$579K
AGL icon
1569
Agilon Health
AGL
$1.6B
– –
-1,179
Closed -$116K
AGX icon
1570
Argan
AGX
$8.37B
– –
-10,138
Closed -$1.03M
AIV
1571
Aimco
AIV
$383M
– –
-27,927
Closed -$252K
ALEX
1572
DELISTED
Alexander & Baldwin
ALEX
– –
-10,869
Closed -$209K
ALKT icon
1573
Alkami Technology
ALKT
$2.11B
– –
-6,449
Closed -$203K
ALL icon
1574
Allstate
ALL
$67.5B
– –
-2,063
Closed -$391K
ALSN icon
1575
Allison Transmission
ALSN
$9.82B
– –
-5,828
Closed -$560K
61 62
63
64 65

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.